Neurona Therapeutics Appoints Dr. Manher Joshi as Chief Medical Officer [Yahoo! Finance]
Atara Biotherapeutics, Inc. (ATRA)
Last atara biotherapeutics, inc. earnings: 2/27 07:30 am
Check Earnings Report
US:NASDAQ Investor Relations:
investors.atarabio.com/investor-relations
Company Research
Source: Yahoo! Finance
cell therapies for disorders of the nervous system, today announced the appointment of Manher (AJ) Joshi, M.D., as Chief Medical Officer. “We are excited to welcome AJ, and we are confident that his extensive cell therapy expertise and executive leadership skillset will complement the Neurona team and guide our company's next phase of growth,” said Cory R. Nicholas, Ph.D., Neurona's Co-Founder and Chief Executive Officer. “AJ's decades of clinical development and commercialization experience, across a variety of neuro-focused indications, strengthen our capabilities as we advance our pipeline of cellular therapeutic candidates for neurological diseases, including NRTX-1001 in drug-resistant focal epilepsy.” “I'm delighted to be joining Neurona Therapeutics at such a critical time in the company's history,” said Manher Joshi, MD, Chief Medical Officer of Neurona Therapeutics. “The data presented to date from the ongoing Phase 1/2 trial in drug-resistant unilateral temporal lobe epi
Show less
Read more
Impact Snapshot
Event Time:
ATRA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ATRA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ATRA alerts
High impacting Atara Biotherapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
ATRA
News
- Atara Biotherapeutics Announces 1-for-25 Reverse Stock Split [Yahoo! Finance]Yahoo! Finance
- Atara Biotherapeutics Announces 1-for-25 Reverse Stock SplitBusiness Wire
- Atara Biotherapeutics, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)Business Wire
- Atara Biotherapeutics to Participate in the Goldman Sachs 45th Annual Global Healthcare ConferenceBusiness Wire
- Atara Biotherapeutics Presents Preclinical Data on ATA3219, an Allogeneic CD19-Targeted CAR T Therapy for the Treatment of B-Cell Driven Autoimmune Diseases, at the ISCT 2024 Annual Meeting [Yahoo! Finance]Yahoo! Finance
ATRA
Earnings
- 5/9/24 - Beat
ATRA
Sec Filings
- 6/20/24 - Form 8-K
- 6/17/24 - Form 8-K
- 6/11/24 - Form S-8
- ATRA's page on the SEC website